Caplin Point gets USFDA nod for Glycopyrrolate injection
Caplin Point Laboratories has said that Caplin Steriles (wholly-owned subsidiary) has been granted final approval by the USFDA for its Abbreviated New22-03-2019
Caplin Point gets USFDA nod for Glycopyrrolate injection
Caplin Point Laboratories has said that Caplin Steriles (wholly-owned subsidiary) has been granted final approval by the USFDA for its Abbreviated NewCaplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate.CAPLIN POINT LABORATORIES LTD. - 524742 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Caplin Point Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Allotment
ALLOTMENT OF EQUITY SHARES UNDER EMPLOYEE STOCK OPTION PLAN-2015.Caplin Point Laboratories Ltd - 524742 - Un-Audited Financial Results (Consolidated & Standalone) For Third Quarter/Nine Months Ended December 31,2018.
Un-audited Financial Results (Consolidated & Standalone) for third quarter/nine months ended December 31,2018.Caplin Point Laboratories Ltd - 524742 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Caplin Point Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.Caplin Point Laboratories Ltd - 524742 - EARNINGS CONFERENCE CALL ON FEBRUARY 11,2019
EARNINGS CONFERENCE CALL ON FEBRUARY 11,2019CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for CONSIDERING THE UN-AUDITED FINANCIAL RESULTS FOR THIRD QUARTER/NINE MONTHS ENDED DECEMBER 31,2018.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve the Un-audited Financial Results for third quarter/nine months ended December 31, 2018.CAPLIN POINT LABORATORIES LTD. - 524742 - Shareholding for the Period Ended December 31, 2018
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here